DNA alkylation is a key cellular event in the mechanism of action of clinical anticancer drugs, chemical mutagens, and carcinogens. 1 The nitrogen and oxygen atoms of purines are preferentially alkylated, with the affinity for a particular base depending on the sequence of neighboring bases. It is most likely that the sequence selectivity of the agent is important in determining the nature of the biological response. 2 Methods based on molecular biology have been used extensively to determine the sequence selectivity of alkylation. 3 Such assays are extremely sensitive and may be quantitative; however, they do not yield direct information concerning the structure of the ligand-DNA adducts. NMR spectroscopy 4 and X-ray crystallography 5 enable detailed structural characterization but are time consuming and require large amounts (micromoles) of material. Mass spectrometry should complement these techniques by providing a rapid and sensitive means of determining the sequence selectivity of alkylation and, at the same time, provide some structural detail about the adducts. 6 Several early studies concerned with the sequencing of ligand-DNA adducts by mass spectrometry have involved tandem mass spectrometry (MS/ MS) following fast atom bombardment (FAB) ionization. 7 This approach is limited, however, by the relatively poor efficiency of FAB ionization for oligonucleotides. 8 In contrast, electrospray ionization (ESI) has allowed mass measurement of relatively large oligonucleotides, including modified oligonucleotides, 9 an intact plasmid DNA, 10 and noncovalent drug-DNA complexes. 11 Tandem mass spectrometry following electrospray ionization (ESI-MS/MS) has been used for the location of modified bases within oligonucleotides and for the characterization of synthetic oligonucleotides which contain "unnatural" bases in their sequence. 12 To date, however, there have been no reports of the use of ESI-MS/MS for the sequencing of covalent, ligand-oligonucleotide adducts. 13 Hedamycin (Figure 1) is a naturally-occurring antitumor antibiotic that binds to double-stranded DNA by both intercalation and alkylation. DNA sequencing shows that alkylation occurs exclusively at guanine bases, but with a distinct preference for guanines located in 5′-CGT-3′ and 5′-CGG-3′ sequences. 14 NMR-derived solution structures of hedamycin covalently bound to double-stranded oligonucleotides show that the anthrapyrantrione chromophore of the ligand threads the double helix, placing the two amino sugars in the minor groove and the alkylating bis-epoxide side chain in the major groove. 15 Our previous studies of hedamycin-DNA binding by ESI-MS have confirmed that hedamycin significantly increases duplex stability and provided strong evidence for the formation of specifically, base-paired duplexes in the gas phase. 16 We demonstrate here that ESI-MS/MS can be used to determine unequivocally the sequence selectivity of base alkylation by a DNA-binding antitumor drug, using hedamycin as a model.ESI-MS/MS spectra of multiply-charged anions of u...